Bioventus Inc. (BVS) NASDAQ

$5.30 0.14 (2.71%)

Market Cap: $327.14M

As of 03/28/24 12:26 PM EDT. Market open.

(BVS)

Bioventus Inc. (BVS)
NASDAQ

$5.30
0.14 (2.71%)

Market Cap: $327.14M

As of 03/28/24 12:26 PM EDT. Market open.

Add to Portfolio

bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. bioventus accomplishes this with its orthobiologic products for musculoskeletal healing, regeneration and related biosurgery that engage and enhance the body’s natural healing processes. the company has two product portfolios for orthobiologics, bioventus ... read more

bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. bioventus accomplishes this with its orthobiologic products for musculoskeletal healing, regeneration and related biosurgery that engage and enhance the body’s natural healing processes. the company has two product portfolios for orthobiologics, bioventus active healing therapies and bioventus surgical, which are created through a combination of internal product development, product/business acquisition, and distribution agreements. established in 2012, bioventus is privately held and headquartered in durham, nc. the company has nearly 600 employees worldwide and its international headquarters is in hoofddorp, the netherlands. bioventus also has offices in memphis, tn, australia and canada, and a research and development site is located in boston. bioventus works with patients, payers and health care providers throughout the world, and generat read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
1,190
Address
.
PRICE CHART FOR BIOVENTUS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.22
Previous Close
$5.16
Days Range
$5.11 - $5.27
52 week range
$0.80 - $6.08
Volume
27,486
Avg. Volume (30 days)
178,719
Market Cap
$327.14M
Dividend Yield
-
P/E
(2.09)
Shares Outstanding
63,400,000
Open
$5.22
Previous Close
$5.16
Days Range
$5.11 - $5.27
52 week range
$0.80 - $6.08
Volume
27,486
Avg. Volume (30 days)
178,719
Market Cap
$327.14M
Dividend Yield
-
P/E
(2.09)
Shares Outstanding
63,400,000
FINANCIAL STATEMENTS FOR BIOVENTUS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOVENTUS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Singleton Mark LeonardSVP & CFOMar 22, 2024 Sale$5.395,54129,85325,665Mar 25, 2024, 05:36 PM
D'Adamio AnthonySVP & General CounselMar 15, 2024 Sale$5.463,12517,06351,371Mar 20, 2024, 06:41 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerMar 15, 2024 Sale$5.461,2176,64514,067Mar 20, 2024, 06:41 PM
Bihl Anthony P IIIInterim CEOAug 18, 2023 Buy$4.1426,595110,07126,595Aug 22, 2023, 06:20 PM
Bihl Anthony P IIIInterim CEOAug 18, 2023 Buy$4.1413,29055,005138,290Aug 22, 2023, 06:20 PM
Bartholdson John A.DirectorAug 14, 2023 Buy$4.7914,98571,7536,833,857Aug 15, 2023, 05:48 PM
Bartholdson John A.DirectorAug 11, 2023 Buy$4.6050,037229,9356,818,872Aug 15, 2023, 05:48 PM
Juniper Investment Company, LLC10% OwnerAug 11, 2023 Buy$4.5650,037228,1696,818,872Aug 15, 2023, 04:05 PM
Juniper Investment Company, LLC10% OwnerAug 10, 2023 Buy$4.47111,848499,9616,768,835Aug 15, 2023, 04:05 PM
Juniper Investment Company, LLC10% OwnerAug 14, 2023 Buy$4.7914,98571,7786,833,857Aug 15, 2023, 04:05 PM
Bartholdson John A.DirectorAug 10, 2023 Buy$4.47111,848500,4196,768,835Aug 14, 2023, 06:04 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJul 03, 2023 Sale$2.833941,11511,828Jul 05, 2023, 05:11 PM
Bartholdson John A.DirectorJun 15, 2023 Buy$3.61110,180397,6626,656,987Jun 16, 2023, 04:30 PM
Bartholdson John A.DirectorJun 14, 2023 Buy$3.24181,946589,5236,546,807Jun 16, 2023, 04:30 PM
Bartholdson John A.DirectorJun 12, 2023 Buy$2.92395,4011,154,2556,304,537Jun 14, 2023, 05:54 PM
Bartholdson John A.DirectorJun 13, 2023 Buy$3.0560,324183,9106,364,861Jun 14, 2023, 05:54 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerOct 03, 2022 Sale$7.005840610,222Jun 08, 2023, 08:05 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJul 01, 2022 Sale$6.735839010,280Jun 08, 2023, 08:05 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerApr 01, 2022 Sale$14.071521110,338Jun 08, 2023, 08:05 PM
HAWKINS WILLIAM ADirectorMay 25, 2023 Buy$2.6644,000117,176184,310May 26, 2023, 04:28 PM
HAWKINS WILLIAM ADirectorMay 24, 2023 Buy$2.6944,000118,391140,310May 26, 2023, 04:28 PM
Bihl Anthony P IIIInterim CEOMay 23, 2023 Buy$2.33125,000290,987125,000May 24, 2023, 09:17 PM
Bartholdson John A.DirectorMay 22, 2023 Buy$2.08178,998372,2985,909,136May 23, 2023, 09:16 PM
Bartholdson John A.DirectorMay 19, 2023 Buy$1.941,136,6752,200,8305,730,138May 23, 2023, 09:16 PM
Nosenzo JohnFmr. Chief Commercial OfficerOct 03, 2022 Sale$7.0074987,148Apr 21, 2023, 05:45 PM
Nosenzo JohnFmr. Chief Commercial OfficerJul 01, 2022 Sale$6.739563987,155Apr 21, 2023, 05:45 PM
Nosenzo JohnFmr. Chief Commercial OfficerApr 01, 2022 Sale$14.074056387,250Apr 21, 2023, 05:45 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJul 01, 2022 Sale$6.735839010,280Apr 21, 2023, 05:33 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerApr 01, 2022 Sale$14.071521110,338Apr 21, 2023, 05:33 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerOct 03, 2022 Sale$7.005840610,222Apr 21, 2023, 05:33 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerApr 03, 2023 Sale$1.0711712510,353Apr 05, 2023, 08:54 PM
Singleton Mark LeonardSVP & CFOMar 24, 2023 Sale$1.276,0447,67612,581Mar 27, 2023, 07:27 PM
D'Adamio AnthonySVP & General CounselMar 15, 2023 Sale$1.393,4094,73745,610Mar 16, 2023, 09:21 PM
Reali Kenneth MichaelChief Executive OfficerMar 15, 2023 Sale$1.399,81113,62530,085Mar 16, 2023, 09:19 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerMar 15, 2023 Sale$1.391,3321,8504,624Mar 16, 2023, 09:17 PM
D'Adamio AnthonySVP & General CounselApr 04, 2022 Sale$11.1916,016179,23840,132Apr 05, 2022, 09:16 PM
Nosenzo JohnChief Commercial OfficerApr 04, 2022 Sale$11.1265,963733,50283,932Apr 05, 2022, 09:14 PM
Pavesio AlessandraSVP & Chief Science OfficerApr 04, 2022 Sale$11.1732,997368,425148,309Apr 05, 2022, 09:09 PM
Pavesio AlessandraSVP & Chief Science OfficerFeb 14, 2022 Sale$11.994335,192119,830Feb 16, 2022, 06:29 PM
D'Adamio AnthonySVP & General CounselFeb 14, 2022 Sale$11.991,29415,51318,672Feb 15, 2022, 09:31 PM
Anglum Gregory O.SVP & CFOFeb 14, 2022 Sale$11.991,29415,51855,013Feb 15, 2022, 09:27 PM
Nosenzo JohnChief Commercial OfficerFeb 14, 2022 Sale$11.995346,40143,370Feb 15, 2022, 09:17 PM
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICERFeb 10, 2022 Option Exercise$12.8873,915952,025118,793Feb 14, 2022, 08:43 PM
Nosenzo JohnCHIEF COMMERCIAL OFFICERFeb 10, 2022 Option Exercise$12.8824,205311,76042,434Feb 14, 2022, 08:41 PM
D'Adamio AnthonySVP & General CounselFeb 10, 2022 Option Exercise$12.886,59984,99515,566Feb 14, 2022, 08:37 PM
Anglum Gregory O.SVP & CFOFeb 10, 2022 Option Exercise$12.8819,674253,40151,907Feb 14, 2022, 08:35 PM
Reali Kenneth MichaelCHIEF EXECUTIVE OFFICERSep 09, 2021 Buy$14.811,80026,65811,175Sep 10, 2021, 09:22 AM
Anglum Gregory O.SVP & General CounselFeb 11, 2021 Buy$13.006,00078,0006,000Apr 05, 2021, 04:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Singleton Mark LeonardSVP & CFO03/22/202429,853
D'Adamio AnthonySVP & General Counsel03/15/202417,063
CHURCH KATRINA JSVP & Chief Compliance Officer03/15/20246,645
Bihl Anthony P IIIInterim CEO08/18/2023110,071
Bihl Anthony P IIIInterim CEO08/18/202355,005
Bartholdson John A.Director08/14/202371,753
Bartholdson John A.Director08/11/2023229,935
Juniper Investment Company, LLC10% Owner08/11/2023228,169
Juniper Investment Company, LLC10% Owner08/10/2023499,961
Juniper Investment Company, LLC10% Owner08/14/202371,778
Bartholdson John A.Director08/10/2023500,419
CHURCH KATRINA JSVP & Chief Compliance Officer07/03/20231,115
Bartholdson John A.Director06/15/2023397,662
Bartholdson John A.Director06/14/2023589,523
Bartholdson John A.Director06/12/20231,154,255
Bartholdson John A.Director06/13/2023183,910
CHURCH KATRINA JSVP & Chief Compliance Officer10/03/2022406
CHURCH KATRINA JSVP & Chief Compliance Officer07/01/2022390
CHURCH KATRINA JSVP & Chief Compliance Officer04/01/2022211
HAWKINS WILLIAM ADirector05/25/2023117,176
HAWKINS WILLIAM ADirector05/24/2023118,391
Bihl Anthony P IIIInterim CEO05/23/2023290,987
Bartholdson John A.Director05/22/2023372,298
Bartholdson John A.Director05/19/20232,200,830
Nosenzo JohnFmr. Chief Commercial Officer10/03/202249
Nosenzo JohnFmr. Chief Commercial Officer07/01/2022639
Nosenzo JohnFmr. Chief Commercial Officer04/01/2022563
CHURCH KATRINA JSVP & Chief Compliance Officer07/01/2022390
CHURCH KATRINA JSVP & Chief Compliance Officer04/01/2022211
CHURCH KATRINA JSVP & Chief Compliance Officer10/03/2022406
CHURCH KATRINA JSVP & Chief Compliance Officer04/03/2023125
Singleton Mark LeonardSVP & CFO03/24/20237,676
D'Adamio AnthonySVP & General Counsel03/15/20234,737
Reali Kenneth MichaelChief Executive Officer03/15/202313,625
CHURCH KATRINA JSVP & Chief Compliance Officer03/15/20231,850
D'Adamio AnthonySVP & General Counsel04/04/2022179,238
Nosenzo JohnChief Commercial Officer04/04/2022733,502
Pavesio AlessandraSVP & Chief Science Officer04/04/2022368,425
Pavesio AlessandraSVP & Chief Science Officer02/14/20225,192
D'Adamio AnthonySVP & General Counsel02/14/202215,513
Anglum Gregory O.SVP & CFO02/14/202215,518
Nosenzo JohnChief Commercial Officer02/14/20226,401
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER02/10/2022952,025
Nosenzo JohnCHIEF COMMERCIAL OFFICER02/10/2022311,760
D'Adamio AnthonySVP & General Counsel02/10/202284,995
Anglum Gregory O.SVP & CFO02/10/2022253,401
Reali Kenneth MichaelCHIEF EXECUTIVE OFFICER09/09/202126,658
Anglum Gregory O.SVP & General Counsel02/11/202178,000
Load More Insider Transactions
FUNDS WITH A POSITION IN BIOVENTUS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.505,5740.00007%-0.29%Other
GEODE CAPITAL MANAGEMENT, LLC407,4440.00022%5.91%Other
RENAISSANCE TECHNOLOGIES LLC135,2450.0011%69.48%Other
BALYASNY ASSET MANAGEMENT L.P.86,9080.00086%NewEvent Driven
ROYCE & ASSOCIATES LP50,0000.00168%ExitedValue
D. E. SHAW & CO., INC.35,9100.00017%NewOther
GABELLI FUNDS LLC10,0000.00041%-44.44%Event Driven, Growth, Activists
CHANGE IN SHARES OUTSTANDING FOR BIOVENTUS INC
STOCK BUYBACKS FOR BIOVENTUS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.45%
1Q
12/31/2023
07/01/2023
0.89%
2Q
12/31/2023
04/01/2023
1.58%
3Q
12/31/2023
12/31/2022
1.90%
4Q
12/31/2023
10/01/2022
2.32%
5Q
12/31/2023
07/02/2022
2.65%
6Q
12/31/2023
04/02/2022
4.33%
7Q
12/31/2023
12/31/2021
38.78%
8Q
12/31/2023
10/02/2021
50.84%
9Q
12/31/2023
07/03/2021
50.95%
10Q
12/31/2023
04/03/2021
50.98%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.45%
1Q
07/01/2023
0.89%
2Q
04/01/2023
1.58%
3Q
12/31/2022
1.90%
4Q
10/01/2022
2.32%
5Q
07/02/2022
2.65%
6Q
04/02/2022
4.33%
7Q
12/31/2021
38.78%
8Q
10/02/2021
50.84%
9Q
07/03/2021
50.95%
10Q
04/03/2021
50.98%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIOVENTUS INC
LOADING...